Form 4: Director Daniel Hancock Increases Stake in Cryoport
Statement of Changes in Beneficial Ownership
Director Daniel M. Hancock acquired 10,350 shares of restricted stock and 16,077 stock options in Cryoport, Inc.
Summary
- Director Daniel M. Hancock received a grant of 10,350 restricted stock units (RSUs) on June 5, 2026.
- The RSUs vest in full on June 5, 2027, converting to common stock on a one-for-one basis.
- The director was also granted 16,077 stock options with an exercise price of $15.70.
- The stock options vest in 1/12th increments monthly, beginning July 5, 2026, and expiring June 5, 2033.
- Following these transactions, the director's total direct beneficial ownership is 69,052 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation, which is expected and does not signal a change in company strategy.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Increased equity stake for a member of the board of directors.
Negatives
- Dilutive impact of new equity grants on existing shareholders.
Risks
- Market price volatility affecting the value of the granted options and restricted stock.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on director compensation.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize long-term performance and align leadership with shareholder outcomes in the life sciences logistics sector.
Comparison to Industry Standards
- The use of RSU and option grants is consistent with standard executive and director compensation packages for mid-cap biotechnology and life sciences companies.
- Vesting schedules of one year for RSUs and monthly vesting over one year for options are typical for board-level compensation.
Stakeholder Impact
- Shareholders may experience minor dilution from the issuance of new equity.
Next Steps
- Vesting of stock options beginning July 5, 2026.
- Vesting of restricted stock units on June 5, 2027.
Key Dates
| Date | Description |
|---|---|
| 06/05/2026 | Date of transaction and grant of restricted stock and options. |
| 07/05/2026 | Commencement of monthly vesting for stock options. |
| 06/05/2027 | Full vesting date for restricted stock units. |
| 06/05/2033 | Expiration date for stock options. |
Keywords
Cryoport, CYRX, Insider Trading, Form 4, Director Compensation, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.